Able Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Able Wealth Management's LLY Position: Q3 2026 in Review
Able Wealth Management reduced its Eli Lilly (LLY) stake by 15% in Q3 2026, selling an estimated $87.3K and leaving 408 shares worth $466K. The position accounts for 0.1% of the portfolio, ranked #87.
Able Wealth Management first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. The position peaked at $569K in Q2 2026. 1,645 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Able Wealth Management held 408 shares of Eli Lilly worth $466K as of Q3 2026.
- Able Wealth Management sold 74 Eli Lilly shares in Q3 2026, an estimated $87.3K.
- Eli Lilly made up 0.1% of Able Wealth Management's portfolio in Q3 2026, its #87 holding.
- Able Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
- Able Wealth Management's Eli Lilly position peaked at $569K in Q2 2026.
- 1,645 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Able Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.